Franklin M. Berger

Insider Reports History

Entity
Individual
Location
1000 Marina Blvd, Ste 200, Brisbane, CA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Franklin M. Berger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Franklin M. Berger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ESSA Pharma Inc. Director Common Shares 784K $7.85M $10.01 Nov 21, 2023 Direct
Atea Pharmaceuticals, Inc. Director Common Stock 452K $1.29M $2.85 Dec 10, 2024 Direct
Atea Pharmaceuticals, Inc. Director Restricted Stock Units 29.6K $103K $3.49 Jun 21, 2024 Direct
Rain Oncology Inc. Director Common Stock, par value $0.001 per share 0 $0 $1.21 Jan 26, 2024 Direct
ESSA Pharma Inc. Director Options 50K Mar 25, 2024 Direct
Kezar Life Sciences, Inc. Director Stock Option (right to buy) 50K Jun 20, 2024 Direct
Atea Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 41.2K Jun 21, 2024 Direct
Atreca, Inc. Director Stock Option (right to buy) 12K Jun 13, 2023 Direct
Rain Oncology Inc. Director Stock Option (Right to Buy) 0 Jan 26, 2024 Direct

Insider Reports Filed by Franklin M. Berger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVIR Atea Pharmaceuticals, Inc. Dec 10, 2024 1 -$1.02M 4 Dec 12, 2024 Director
AVIR Atea Pharmaceuticals, Inc. Jun 21, 2024 2 $0 4 Jun 21, 2024 Director
KZR Kezar Life Sciences, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
AVIR Atea Pharmaceuticals, Inc. Jun 16, 2024 2 $0 4 Jun 18, 2024 Director
EPIX ESSA Pharma Inc. Mar 25, 2024 1 $0 4 Mar 28, 2024 Director
RAIN Rain Oncology Inc. Jan 26, 2024 4 $0 4 Jan 26, 2024 Director
EPIX ESSA Pharma Inc. Nov 21, 2023 1 $133K 4 Nov 22, 2023 Director
EPIX ESSA Pharma Inc. Nov 2, 2023 2 $420K 4 Nov 16, 2023 Director
RAIN Rain Oncology Inc. Aug 9, 2023 1 $0 4 Aug 11, 2023 Director
KZR Kezar Life Sciences, Inc. Jul 24, 2023 4 $0 4 Jul 26, 2023 Director
AVIR Atea Pharmaceuticals, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
KZR Kezar Life Sciences, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
BCEL Atreca, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
EPIX ESSA Pharma Inc. Dec 14, 2022 7 -$729K 4 Jan 5, 2023 Director
RAIN Rain Therapeutics Inc. Nov 21, 2022 2 $988K 4 Nov 23, 2022 Director
AVIR Atea Pharmaceuticals, Inc. Nov 11, 2022 2 -$215K 4 Nov 15, 2022 Director
RAIN Rain Therapeutics Inc. Nov 8, 2022 1 $250K 4 Nov 14, 2022 Director
EPIX ESSA Pharma Inc. Jun 29, 2022 1 $0 4 Nov 1, 2022 Director
AVIR Atea Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
KZR Kezar Life Sciences, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
BCEL Atreca, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
RAIN Rain Therapeutics Inc. Jun 1, 2022 1 $0 4 Aug 19, 2022 Director
KZR Kezar Life Sciences, Inc. Mar 18, 2022 3 $1.3M 4 Mar 22, 2022 Director
RAIN Rain Therapeutics Inc. Sep 21, 2021 1 $54.1K 4 Sep 23, 2021 Director
KZR Kezar Life Sciences, Inc. Sep 21, 2021 6 $170K 4 Sep 23, 2021 Director
KZR Kezar Life Sciences, Inc. Jun 28, 2021 1 $0 4 Jun 30, 2021 Director
AVIR Atea Pharmaceuticals, Inc. Jun 18, 2021 1 $0 4 Jun 21, 2021 Director
BCEL Atreca, Inc. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
RAIN Rain Therapeutics Inc. May 14, 2021 1 $0 4 May 18, 2021 Director